Cargando…
An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy
As hematopoietic progenitors supply a large number of blood cells, therapeutic strategies targeting hematopoietic progenitors are potentially beneficial to eliminate unwanted blood cells, such as leukemic cells and immune cells causing diseases. However, due to their pluripotency, targeting those ce...
Autores principales: | Izumi, Yuta, Kanayama, Masashi, Shen, Zhongchuzi, Kai, Masayuki, Kawamura, Shunsuke, Akiyama, Megumi, Yamamoto, Masahide, Nagao, Toshikage, Okada, Keigo, Kawamata, Norihiko, Toyota, Shigeo, Ohteki, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937628/ https://www.ncbi.nlm.nih.gov/pubmed/33692791 http://dx.doi.org/10.3389/fimmu.2021.618081 |
Ejemplares similares
-
Myeloid-like B cells boost emergency myelopoiesis through IL-10 production during infection
por: Kanayama, Masashi, et al.
Publicado: (2023) -
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2
por: Ishida, Shinya, et al.
Publicado: (2018) -
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report
por: Tanaka, Keisuke, et al.
Publicado: (2017) -
FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia
por: Nogami, Ayako, et al.
Publicado: (2015) -
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis
por: Tanaka, Keisuke, et al.
Publicado: (2023)